Exane BNP Paribas resumed coverage of WestRock with a rating of Outperform
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/29/2024 | Buy → Neutral | Seaport Research Partners | |
| 1/8/2024 | Outperform | Exane BNP Paribas | |
| 11/17/2023 | Hold → Buy | Argus | |
| 4/20/2023 | $38.00 → $40.00 | Neutral → Buy | BofA Securities |
| 3/20/2023 | $34.00 → $32.00 | Neutral → Buy | Citigroup |
| 2/13/2023 | Buy → Hold | Argus | |
| 6/21/2022 | $53.00 → $45.00 | Buy → Neutral | Citigroup |
| 2/4/2022 | $43.00 → $42.00 | Underweight | Keybanc |